Dopaminergic Mechanisms of Cognitive Flexibility: An [ 18 F]Fallypride PET Study
Journal of Nuclear Medicine · 2025
DOI: 10.2967/jnumed.124.268317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Isabelle Miederer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; isabelle.miederer@unimedizin-ma…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Benzamides, Cognition, Dopamine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Cognitive flexibility is the ability to appropriately adapt one's thinking and behavior to changing environmental demands and is conceptualized as an aspect of executive function. The dopamine system has been implicated in cognitive flexibility; however, a direct, that is, neurochemical, link to cognitive flexibility has not been shown yet. The aim of this study was, therefore, to investigate how cognitive flexibility is mediated by dopaminergic signaling in the ventromedial prefrontal cortex (vmPFC).
Methods
Eighteen participants were measured in a PET study with 174 ± 12 MBq of the D2/3 receptor ligand [18F]fallypride in a block design with 2 parts. While participants processed 2 tasks sequentially without rule switching on a computer screen in the first part of the PET scan, they had to flexibly switch between the 2 task rules after 100 min after injection in the second part. Dopamine release (γ) was quantified using the linearized simplified reference region model contrasting the 2 task blocks (switching vs. no-switching/baseline).
Results
The statistical analysis of the parametric γ-images showed that the increased cognitive demand during task switching induced a displacement of the D2/3 receptor ligand [18F]fallypride in the vmPFC (maximum T value = 13.8; cluster size: 528 voxels; familywise error rate-corrected P < 0.001; mean γ = 0.022 ± 0.006 min-1). Furthermore, a correlation between behavioral switch costs and vmPFC [18F]fallypride displacement suggested that participants showing greater dopamine release were more efficient in task switching.
Conclusion
To our knowledge, this is the first experimental PET study to show direct involvement of dopamine in the vmPFC in a task-switching paradigm, confirming model assumptions about the neurochemical basis of cognitive flexibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; isabelle.miederer@unimedizin-mainz.de.
- Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Psychology, Goethe University Frankfurt, Frankfurt am Main, Germany.
- Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
- Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health, University of Tübingen, Tübingen, Germany.
- Department of Nuclear Chemistry, Johannes Gutenberg University Mainz, Mainz, Germany; and.
Zitieren
APA
Miederer, I., Buchholz, H. G., Rademacher, L., Eckart, C., Kraft, D., Piel, M., Fiebach, C. J., & Schreckenberger, M. (2025). Dopaminergic Mechanisms of Cognitive Flexibility: An [ 18 F]Fallypride PET Study. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268317
Vancouver
Miederer I, Buchholz HG, Rademacher L, Eckart C, Kraft D, Piel M, et al. Dopaminergic Mechanisms of Cognitive Flexibility: An [ 18 F]Fallypride PET Study. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268317
BibTeX
@article{Miederer2025,
author = {Miederer, Isabelle and Buchholz, Hans-Georg and Rademacher, Lena and Eckart, Cindy and Kraft, Dominik and Piel, Markus and Fiebach, Christian J and Schreckenberger, Mathias},
title = {Dopaminergic Mechanisms of Cognitive Flexibility: An [ 18 F]Fallypride PET Study},
journal = {Journal of Nuclear Medicine},
year = {2025},
doi = {10.2967/jnumed.124.268317}
}
EUVIMED